Infrastructure's Slow Burn: Why Venture Capital's 'Blitzscaling' Model Fails Data-Intensive Companies
Why blitzscaling fails foundational infrastructure. Explore why data-intensive platforms require patient capital and disciplined technical execution.
Patient Capital for Patient Builders: Junagal's Venture Strategy
Junagal's long-term venture building philosophy. Learn how patient capital unlocks durable innovation and compounds enterprise ownership in the UK.
The Mathematics of Compounding Ownership: Building Exponential Value in Venture
Explore the mathematics of compounding equity ownership in venture studios, and how retaining controlling stakes creates exponential long-term value.
The Operator-Founder Advantage: Why Execution Expertise Is Now Non-Negotiable
Visionary ideas are cheap; execution is scarce. Why operator-founders with hands-on technical expertise dominate enduring technology venture building.
The Linchpin of Long-Term Growth: Aligning Capital with Operational Reality
Why enduring ventures require synchronizing capital allocation with operational reality, fueling sustainable growth instead of artificial milestones.
Beyond the Hype: When Venture Capital Isn't the Right Path
Venture capital is not a universal fit. Discover why thriving outside institutional VC preserves founder equity, autonomy, and lasting control.
Permanent Capital: The Patient Path to Building Enduring Technology Businesses
Unlike traditional VC's pressure for quick exits, permanent capital fosters patient compounding, building enduring technology assets with high moats.
When to Say No: Why Venture Capital Isn't Always the Answer
When to say no to institutional VC. Identify early warning signs of misaligned fund incentives and choose alternative capitalization models.
Balancing Act: Capital Efficiency vs. Capital Intensity in Long-Term Technology Ventures
Mastering the tradeoff between capital efficiency and strategic capital intensity to build high-barrier, compounding technology enterprises.
Beyond the Exit: Building Perpetual Value in the Venture Studio Model
The power of exit-free company building: generating compounding cash flows and perpetual enterprise value without the forced pressure of a hasty sale.
Beyond Financials: The Power of Compounding Ownership in Venture Building
How compounding ownership acts like compound interest in venture building, preserving high-conviction equity stakes across defensible technology assets.
Unlocking Exponential Growth: Why Patient Capital is a Strategic Advantage for Tech Ventures
Why patient capital provides a decisive competitive edge, freeing technical founders to architect deep moats and achieve enduring compounding growth.